Cerebral blood flow (CBF) is an emerging biomarker of Alzheimer’s disease (AD). To correlate CBF to other known measures of AD, such as cortical thinning and volume loss, we assessed perfusion differences between a 2xTg-AD mouse model and age-matched wild-type mice using a FAIR RARE MRI sequence. Our results demonstrate greater systolic blood pressure (SBP) in AD mice as they age as well as hypoperfusion within the cerebral cortex at 12 months of age.
This abstract and the presentation materials are available to members only; a login is required.